HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

SHE:002437 Revenue

HARBIN GLORIA PHARMACEUTICALS Co., LTD had revenue of 467.96M CNY in the quarter ending June 30, 2026, a decrease of -14.64%. This brings the company's total for the last twelve months to 2.04B, down -11.90% year-over-year. In the year 2025, HARBIN GLORIA PHARMACEUTICALS Co., LTD had annual revenue of 2.14B, down -12.51%. That makes HARBIN GLORIA PHARMACEUTICALS Co., LTD the 14,402nd largest company in the world by revenue and 2,565th in China.

• Revenue (ttm): 2.04B
• Revenue Growth: -11.90%
• P/S Ratio: 3.36
• Revenue / Employee: 869.37K
• Employees: 2,350
• Market Cap: 6.87B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Chemical Medicine 1.95B 91.3%
• Traditional Chinese Medicine 180.56M 8.5%
• Others 4.38M 0.2%

By Geography

Chart

• China 2.13B 99.8%
• Overseas 5.31M 0.2%

Fiscal year ended Dec 31, 2025 See the full SHE:002437 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.14B	-305.28M	-12.51%
Dec 31, 2024	2.44B	-185.31M	-7.06%
Dec 31, 2023	2.63B	-481.91M	-15.51%
Jan 1, 2023	3.11B	-37.37M	-1.19%
Jan 1, 2022	3.15B	90.36M	2.96%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error